GU Cancers Symposium 2014

Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer - Abstract April 24, 2014

GU Cancers Symposium 2014 - Axitinib: Common questions related to real-world use of a new treatment option in advanced renal cell carcinoma - Poster February 5, 2014

GU Cancers Symposium 2014 - Heterogeneity of intermediate prognosis patients with metastatic renal cell cancer treated with sunitinib - Poster February 5, 2014

GU Cancers Symposium 2014 - Impact of angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database - Poster February 5, 2014

GU Cancers Symposium 2014 - Correlation between patient-reported fatigue and hemoglobin levels in metastatic renal cell carcinoma patients receiving sunitinib - Poster February 5, 2014

GU Cancers Symposium 2014 - Growth kinetics and outcomes of clinical T1b renal masses under active surveillance - Poster February 5, 2014

GU Cancers Symposium 2014 - Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma - Poster February 5, 2014

GU Cancers Symposium 2014 - Open-label, phase II RAPTOR study of everolimus for papillary mRCC: Efficacy in type 1 and type 2 histology - Poster February 5, 2014

GU Cancers Symposium 2014 - In vitro and in vivo effects of the mTOR inhibitors everolimus and temsirolimus - Poster February 5, 2014

GU Cancers Symposium 2014 - Everolimus as second-line therapy for metastatic renal cell carcinoma after one previous VEGF-targeted therapy: Final results of the noninterventional change study - Poster February 5, 2014

GU Cancers Symposium 2014 - Biomarker analysis from a phase III trial (GOLD) of dovitinib vs sorafenibin patients with metastatic renal cell carcinoma after one prior VEGF pathway-targeted therapy and one prior mTOR inhibitor therapy - Poster February 5, 2014

GU Cancers Symposium 2014 - Second-line prescribing preferences of U.S.-based medical oncologists following first-line TKI in patients with metastatic clear cell renal cell carcinoma - Poster February 4, 2014

GU Cancers Symposium 2014 - Somatic genomic alterations in urothelial cancer: Results of the Cancer Genome Atlas (TCGA) bladder cancer analysis - Poster February 4, 2014

GU Cancers Symposium 2014 - Premature termination of genitourinary cancer clinical trials - Poster February 4, 2014

GU Cancers Symposium 2014 - Consideration of height-based rather than weight-based dosing as a more appropriate method of treating with radium-223 - Poster February 4, 2014

GU Cancers Symposium 2014 - Clinical and biologic factors for immune response to sipuleucel-T for metastatic castrate-resistant prostate cancer - Poster February 4, 2014

GU Cancers Symposium 2014 - Increase in bone scan index during abiraterone treatment in relation to reduced survival in mCRPC patients - Poster February 4, 2014

GU Cancers Symposium 2014 - Predicting radical prostatectomy outcome among men who upgrade from clinical Gleason 6 to pathologic Gleason 7 - Poster February 4, 2014

GU Cancers Symposium 2014 - The effect of cell cycle progression score on treatment decisions in prostate cancer: Results of an ongoing registry trial - Poster February 4, 2014

GU Cancers Symposium 2014 - Cell cycle progression score to predict metastatic progression of clear cell renal cell carcinoma after resection - Poster February 4, 2014

Page 1 of 6

E-Newsletters

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.